MSF, Doctors Without Borders, MSF activities in South Africa

South Africa

In South Africa, Doctors Without Borders (MSF) focused on training health staff to strengthen the response to both communicable and non-communicable diseases.

To ensure an integrated approach for all non-communicable diseases (NCDs), efficient use of resources, collective advocacy, and full community involvement, in 2024, MSF partnered with other humanitarian and health-focused NGOs in Amathole, where our project for non-communicable diseases is located, to form the Amathole District Partners forum, a platform where we can develop joint strategies. 

MSF teams were also a key partner in an exercise assessing the country’s capacity to prevent, detect, and respond to public health emergencies, and to strengthen the health security system, which was successfully completed in the last quarter of 2024. 

Our activities in 2024 in South Africa

Data and information from the International Activity Report 2024.

MSF activities in South Africa in 2024 In South Africa, Doctors Without Borders (MSF) focused on training health staff to strengthen the response to both communicable and non-communicable diseases.
MSF, Doctors Without Borders, MSF activities in South Africa

Since 2022, MSF has been running a non-communicable diseases (NCDs) project in Butterworth, Eastern Cape province. With the Department of Health, MSF provided training on hypertension and diabetes to nurses, community health workers, and data entry clerks in Mnquma subdistrict. Following the training, we donated vital signs monitors and digital scales with stadiometers to health facilities, and closely supported healthcare facilities, with improvements to infrastructure and logistics. We also conducted health education training for community-based organisations, and ran health promotion sessions on NCDs in the community and through social media and radio.  

The Department of Health approved three external pick-up points for medication, which MSF equipped. Pick-up points are managed by independent healthcare providers, who dispense the medication free-of-charge to patients, on behalf of the government.

To ensure an integrated approach for all NCDs, efficient use of resources, collective advocacy, and full community involvement, MSF partnered with other humanitarian and health-focused NGOs in Amathole, where our project for non-communicable diseases is located, to form the Amathole District Partners forum, a platform where we can develop joint strategies.    

In 2024, we trained Department of Health staff in digital health promotion to equip them with the skills to respond to disease outbreaks. Following the training, we supported the launch of a two-week digital campaign to raise awareness of mpox, which reached millions of people.  

We were also a key partner in an exercise assessing the country’s capacity to prevent, detect, and respond to public health emergencies, and to strengthen the health security system, which was successfully completed in the last quarter of 2024. 

 

 
MSF_Protest_At_J&J_Offices_In_SA_MSF288569
Access to medicines

MSF calls again on J&J to withdraw/abandon extended patents on lifesaving TB drug

Latest News 18 Jul 2023
 
MSF, Doctors Without Borders, TB
Tuberculosis

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Press Release 14 Jul 2023
 
MSF, Doctors Without Borders, cholera outbreaks in Southern Africa
Cholera

If we can’t avoid people getting sick from cholera, we must at least avoid them dying from it

Latest News 22 Jun 2023
 
MSB158538_cholera
Cholera

Cholera Treatment Unit supported by MSF plays key role in Hammanskraal cholera response

Latest News 1 Jun 2023
 
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
Drug-resistant TB

TAC and MSF intervene in a case for a lifesaving cystic fibrosis drug priced at over R5 million

Press Release 10 May 2023
 
MSF, Doctors Without Borders, India rejects Johnson & Johnson patent extension attempt
Drug-resistant TB

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Press Release 23 Mar 2023